i2Lab

​

​

2020

​

2020 Nov

Kinoshita S, Cortright K, Crawford A, Mizuno Y, Yoshida K, Hilty D, Guinart D, Torous J, Correll CU, Castle DJ, Rocha D, Yang Y, Xiang YT, Kølbæk P, Dines D, ElShami M, Jain P, Kallivayalil R, Solmi M, Favaro A, Veronese N, Seedat S, Shin S, de Pablo GS, Chang CH, Su KP, Karas H, Kane JM, Yellowlees P, Kishimoto T†. Changes in Telepsychiatry Regulations during the COVID-19 Pandemic: 17 Countries and Regions' Approaches to an Evolving Healthcare Landscape. Psychol Med. 2020 Nov 27:1-33.

​

2020 Oct

Horigome T, Kurokawa S, Sawada K, Kudo S, Shiga K, Mimura M, Kishimoto T†. Virtual reality exposure therapy for social anxiety disorder: a systematic review and meta-analysis. Psychol Med. 2020 Oct 19:1-11. 

​

2020 Sep

Takamiya A, Liang KC, Nishikata S, Tarumi R, Sawada K, Kurokawa S, Hirano J, Yamagata B, Mimura M, Kishimoto T. Predicting Individual Remission After Electroconvulsive Therapy Based on Structural Magnetic Resonance Imaging: A Machine Learning Approach. J ECT. 2020 Sep;36(3):205-210. 

​

2020 Sep

Iida H, Iga J, Hasegawa N, Yasuda Y, Yamamoto T, Miura K, Matsumoto J, Murata A, Ogasawara K, Yamada H, Hori H, Ichihashi K, Hashimoto N, Ohi K, Yasui-Furukori N, Tsuboi T, Nakamura T, Usami M, Furihata R, Takaesu Y, Iwamoto K, Sugiyama N, Kishimoto T, Tsujino N, Yamada H, Hishimoto A, Nemoto K, Atake K, Muraoka H, Katsumoto E, Oishi S, Inagaki T, Ito F, Imamura Y, Kido M, Nagasawa T, Numata S, Ochi S, Iwata M, Yamamori H, Fujita J, Onitsuka T, Yamamura S, Makinodan M, Fujimoto M, Takayanagi Y, Takezawa K, Komatsu H, Fukumoto K, Tamai S, Yamagata H, Kubota C, Horai T, Inada K, Watanabe K, Kawasaki H, Hashimoto R. Unmet needs of patients with major depressive disorder - Findings from the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study. Psychiatry Clin Neurosci. 2020 Dec;74(12):667-669.

​

2020 Sep

Yamamoto M, Takamiya A, Sawada K, Yoshimura M, Kitazawa M, Liang KC, Fujita T, Mimura M, Kishimoto T. Using speech recognition technology to investigate the association between timing-related speech features and depression severity. PLoS One. 2020 Sep 11;15(9):e0238726. doi:10.1371/journal.pone.0238726.

​

2020 Sep

Kishimoto T, Takamiya A, Liang KC, Funaki K, Fujita T, Kitazawa M, Yoshimura M, Tazawa Y, Horigome T, Eguchi Y, Kikuchi T, Tomita M, Bun S, Murakami J, Sumali B, Warnita T, Kishi A, Yotsui M, Toyoshiba H, Mitsukura Y, Shinoda K, Sakakibara Y, Mimura M, PROMPT collaborators. The project for objective measures using computational psychiatry technology (PROMPT): Rationale, design, and methodology. Contemp Clin Trials Commun. 2020 Sep 19:100649. doi: 10.1016/j.conctc.2020.100649. PMID: 32913919; PMCID: PMC7473877.

​

2020 Sep

Ichihashi K, Hori H, Hasegawa N, Yasuda Y, Yamamoto T, Tsuboi T, Iwamoto K, Kishimoto T, Horai T, Yamada H, Sugiyama N, Nakamura T, Tsujino N, Nemoto K, Oishi S, Usami M, Katsumoto E, Yamamori H, Tomita H, Suwa T, Furihata R, Inagaki T, Fujita J, Onitsuka T, Miura K, Matsumoto J, Ohi K, Matsui Y, Takaesu Y, Hashimoto N, Iga J, Ogasawara K, Yamada H, Watanabe K, Inada K, Hashimoto R. Prescription patterns in patients with schizophrenia in Japan: First-quality indicator data from the survey of "Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)" project. Neuropsychopharmacol Rep. 2020 Sep;40(3):281-286. 

​

2020 Sep
Takamiya A, Liang KC, Nishikata S, Tarumi R, Sawada K, Kurokawa S, Hirano J, Yamagata B, Mimura M, Kishimoto T†. Predicting Individual Remission After Electroconvulsive Therapy Based on Structural Magnetic Resonance Imaging: A Machine Learning Approach. J ECT. 2020 Sep;36(3):205-210. 

 

2020 Jul
Iiboshi K, Yoshida K, Yamaoka Y, Eguchi Y, Sato D, Kishimoto M, Funaki K,Mimura M, Kishimoto T†. A Validation Study of the Remotely Administered Montreal Cognitive Assessment Tool in the Elderly Japanese Population. Telemed J E Health. 2020 Jul;26(7):920-928. 

​

2020 Jul

Ostuzzi G, Papola D, Gastaldon C, Schoretsanitis G, Bertolini F, Amaddeo F, Cuomo A, Emsley R, Fagiolini A, Imperadore G, Kishimoto T, Michencigh G, Nosé M, Purgato M, Dursun S, Stubbs B, Taylor D, Thornicroft G, Ward PB, Hiemke C, Correll CU, Barbui C. Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations. BMC Med. 2020 Jul 15;18(1):215. 
 

2020 Jun

Sumali B, Mitsukura Y, Liang KC, Yoshimura M, Kitazawa M, Takamiya A, Fujita T, Mimura M, Kishimoto T. Speech Quality Feature Analysis for Classification of Depression and Dementia Patients. Sensors (Basel). 2020 Jun 26;20(12):3599. doi: 10.3390/s20123599. PMID: 32604728; PMCID: PMC7348868.

​

2020 Jun

Takamiya A, Kishimoto T, Hirano J, Nishikata S, Sawada K, Kurokawa, Yamagata B, Kikuchi T, Mimura M. Neuronal network mechanisms associated with depressive symptom improvement following electroconvulsive therapy. Psychchological Medicine. 2020 Jun 1;1-8. doi: 10.1017/S0033291720001518. 

​

2020 Feb

Horigome T, Sumali B, Kitazawa M, Yoshimura M, Liang KC, Tazawa Y, Fujita T, Mimura M, Kishimoto T. Evaluating the severity of depressive symptoms using upper body motion captured by RGB-depth sensors and machine learning in a clinical interview setting: A preliminary study. Comprehensive Psychiatry. 2020 Feb 20;98:152169. doi: 10.1016/j.comppsych.2020.152169. Epub ahead of print. PMID: 32145559.

​

2020 Feb

Tazawa Y, Liang KC, Yoshimura M, Kitazawa M, Kaise Y, Takamiya A, Kishi A, Horigome T, Mitsukura Y, Mimura M, Kishimoto T. Evaluating depression with multimodal wristband-type wearable device: screening and assessing patient severity utilizing machine-learning, Heliyon. 2020 Feb, 6(2), e03274. doi: https://doi.org/10.1016/j.heliyon. 2020.e03274

​

2020 Jul

Ousdal OT, Argyelan M, Narr KL, Abbott C, Wade B, Vandenbulcke M, Urretavizcaya M, Tendolkar I, Takamiya A, Stek ML, Soriano-Mas C, Redlich R, Paulson OB, Oudega ML, Opel N, Nordanskog P, Kishimoto T, Kampe R, Jorgensen A, Hanson LG, Hamilton JP, Espinoza R, Emsell L, van Eijndhoven P, Dols A, Dannlowski U, Cardoner N, Bouckaert F, Anand A, Bartsch H, Kessler U, Oedegaard KJ, Dale AM, Oltedal L; GEMRIC. Brain Changes Induced by Electroconvulsive Therapy Are Broadly Distributed. Biol Psychiatry. 2019 Jul 25. pii: S0006-3223(19)31543-4. doi: 10.1016/j.biopsych.2019.07.010. [Epub ahead of print] PubMed PMID: 31561859.

​

2020

Sanada K, Nakajima S, Kurokawa S, Barcelo-Soler A, Ikuse D, Hirata A, Yoshizawa A, Tomizawa Y, Salas-Valero M, Noda Y, Mimura M, Iwanami A, Kishimoto T. Gut microbiota and majore depressive disorder: A systematic review and meta-analysis, Journal of Affective Disorders, 266, 1-13, 2020

​

2020

Sakishita M, Ogawa C, Tsuchiya K, Iwabuchi T, Kishimoto T, Kano Y. Autism Spectrum Disorder’s Severity Prediction Model Using Utterance Features for Automatic Diagnosis Support. Studies in Computational Intelligence. 843, 83-95. ISSN 1860949X.DOI:10.1007/978-3-030-24409-5_8.2020.

 

2020 Jan

Izumi K, Minato K, Shiga K, Sugio T, Hanashiro S, Cortright K, Kudo S, Fujita T, Sado M, Maeno T, Takebayashi T, Mimura M, Kishimoto T†. Quantification of stress and well-being using pulse, speech, and electrodermal data: Study concept and design. medRxiv [Internet]. 2020 Jan 1;2020.05.01.20082610. Available from: http://medrxiv.org/content/early/2020/05/10/2020.05.01.20082610.abstract

​

​

2019

 

2019 Dec

Takamiya A, Nuninga JO, Mandl RCW, Sommer IEC, Mimura M, Kishimoto T. Volume Increase of the Dentate Gyrus Induced by Electroconvulsive Therapy: Shedding Light on the Clinical Relevance of Plasticity in the Hippocampus. J ECT. 2019 Dec;35(4):e57-e58. 

​

2019 Oct

Kitazawa M, Yoshimura M, Hitokoto H, Sato-Fujimoto Y, Murata M, Negishi K, Mimura M, Tsubota K, Kishimoto T†: Survey of the Effects of Internet Usage on the Happiness of Japanese University Students. Health Qual Life Outcomes. 2019 Oct 11;17(1):151.

​

2019

Mitsukura Y, Sumali B, Tazawa Y, Kishimoto T, and Mimura M. Simple Stress Quantitative Evalution for Healthcare Using Daily KANSEI Detection with EEG Device - Relation between Stress and Healthcare. Modern Environmental Science and Engineering. 2019. 5; 5: 345-350. 

​

2019 

Kishimoto T, Takamiya A, Liang KC, Funaki K, Fujita T, Kitazawa M, Yoshimura M, Tazawa Y, Horigome T, Eguchi Y, Kikuchi T, Tomita M, Bun S, Murakami S, Sumali B, Warnita T, Kishi K, Yotsui M, Toyoshiba H,  Mitsukura Y, Shinoda K, Sakakibara Y, Mimura M. The Project for Objective Measures Using Computational Psychiatry Technology (PROMPT): Rationale, Design, and Methodology. medRxiv 19013011; doi: https://doi.org/10.1101/19013011, 2019

​

2019 Oct

Takamiya A, Kishimoto T, Liang KC, Terasawa Y, Nishikata S, Tarumi R, Sawada K, Kurokawa S, Hirano J, Yamagata B, Mimura M. Thalamic volume, resting-state activity, and their association with the efficacy of electroconvulsive therapy. J Psychiatr Res. 2019 Oct;117:135-141. 

 

2019 Oct

Takaesu Y, Watanabe K, Numata S, Iwata M, Kudo N, Oishi S, Takizawa T, Nemoto K, Yasuda Y, Tagata H, Tsuboi T, Tsujino N, Hashimoto N, Matsui Y, Hori H, Yamamori H, Sugiyama N, Suwa T, Kishimoto T, Hishimoto A, Usami M, Furihata R,Iwamoto K, Fujishiro H, Nakamura T, Mizuno K, Inagaki T, Katsumoto E, Tomita H,Ohi K, Muraoka H, Atake K, Iida H, Nagasawa T, Fujita J, Yamamura S, Onitsuka T, Murata A, Takayanagi Y, Noda H, Matsumura Y, Takezawa K, Iga JI, Ichihashi K,Ogasawara K, Yamada H, Inada K, Hashimoto R. Improvement of psychiatrists' clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study. Psychiatry Clin Neurosci. 2019 Oct;73(10):642-648. doi: 10.1111/pcn.12911. Epub 2019 Aug 22. PubMed PMID:31437336.

​

2019  Sep

Kurokawa S, Kishimoto T, Su KP, Chang JP, Chang HC, Yu X, Rodrigues-Silva N,Nielsen J, Unadkat A, Castle D, Haddad PM, Rocha D, Gadelha A, Kaliora S,Petrides G, Agid O, Tazawa Y, Takamiya A, Horigome T, Kane JM. Psychiatrists' perceptions of medication adherence among patients with schizophrenia: An international survey. Schizophr Res. 2019 Sep;211:105-107. doi:10.1016/j.schres. 2019.07.028. Epub 2019 Jul 29. PubMed PMID: 31371039.

​

2019 Sep

Shinfuku M, Kishimoto T, Uchida H, Suzuki T, Mimura M, Kikuchi T. Effectiveness and safety of long term benzodiazepine use in anxiety disorders: a systematic review and meta-analysis. Int Clin Psychopharmacol. 2019, Sep;34(5):211-221.doi: 10.1097/YIC.0000000000000276. PubMed PMID: 31274696.

​

2019  Sep

Miura G, Misawa F, Kawade Y, Fujii Y, Mimura M, Kishimoto T. Long-Acting Injectables Versus Oral Antipsychotics: A Retrospective Bidirectional Mirror-Image Study. J Clin Psychopharmacol. 2019 Sep/Oct;39(5):441-445. doi:10.1097/JCP.0000000000001082. PubMed PMID: 31415288.

​

2019 Sep

Takamiya A, Plitmane E, Chung JK, Chakravarty M, Graff-Guerrero A, Mimura M, Kishimoto T. Acute and Long-term Effects of Electroconvulsive Therapy on Human Dentate Gyrus. Neuropsychopharmacology. 2019 Sep;44(10):1805-1811.

​

2019 Jul

Ousdal OT, Argyelan M, Narr KL, Abbott C, Wade B, Vandenbulcke M, Urretavizcaya M, Tendolkar I, Takamiya A, Stek ML, Soriano-Mas C, Redlich R, Paulson OB, Oudega ML, Opel N, Nordanskog P, Kishimoto T, Kampe R, Jorgensen A, Hanson LG, Hamilton JP, Espinoza R, Emsell L, van Eijndhoven P, Dols A, Dannlowski U, Cardoner N, Bouckaert F, Anand A, Bartsch H, Kessler U, Oedegaard KJ, Dale AM, Oltedal L; GEMRIC. Brain Changes Induced by Electroconvulsive Therapy Are Broadly Distributed. Biol Psychiatry. 2019 Jul 25. pii:S0006-3223(19)31543-4. doi: 10.1016/j.biopsych.2019.07.010. [Epub ahead of print] PubMed PMID: 31561859.

​

2019 Jul 

Otake-Matsuura M, Tokunaga S, Watanabe K, Abe MS, Sekiguchi T, Sugimoto H, Kishimoto T, Kudo T. Photo-Integrated Conversation Moderated by Robots for Cognitive Health in Older Adults: A Randomized Controlled Trial. medRxiv [Internet]. 2019 Jan 1;19004796. Available from: http://medrxiv.org/content/early/2019/08/21/19004796.abstract

 

2019 Jul 

Matsui K, Tokumasu T, Takekita Y, Inada K, Kanazawa T, Kishimoto T, Takasu S, Tani H, Tarutani S, Hashimoto N, Yamada H, Yamanouchi Y, Takeuchi H. Switching to Antipsychotic Monotherapy vs. Staying on Antipsychotic Polypharmacy in Schizophrenia: A Systematic Review and Meta-analysis. Schizophrenia Research. In press

​

2019 Jul 

Sakishita M, Kishimoto T, Takinami A, Eguchi Y, Kano Y. Large-Scale Dialog Corpus Towards Automatic Mental Disease Diagnosis, Precision Health and Medicine - A Digital Revolution in Healthcare, Studies in Computational Intelligence, volume 843, pp.111-118. DOI:10.1007/978-3-030-24409-5_10, 2019.8.

​

2019 Jul 

Sano Y, Takahata K, Yamamoto Y, Tezuka T, Kurose S, Kurokawa S, Mizushima J,  Mashima K, Okada K, Seki M, Yamagata B, Yoshizaki T, Kishimoto T,  Nakahara T, Ito D, Tabuchi H, Jinzaki M, Mimura M.  CLINICAL CHARACTERIZATION OF 18F‐PI2620 IN ALZHEIMER'S DISEASE AND OTHER TAUOPATHIES. Alzheimer's Association International Conference 2019, Volume15, Issue7S, Part21, 1093-1094, July 2019

​

2019 Jul

Yamamoto Y, Takahata K, Tezuka T, Sano Y, Kurokawa S, Kurose S, Mizushima J,  Mashima K, Okada K, Seki M, Yamagata B, Yoshizaki T, Kishimoto T, Nakahara T,  Tabuchi H, Ito D, Jinzaki M, Mimura M. In vivo retention patterns of 18F‐PI‐2620 in diverse tauopathies and assessments of those resemblance to pathognomonic distribution of tau deposits. Alzheimer's Association International Conference 2019, Volume15, Issue7S, Part21, 1085-1085, July 2019

​

2019 Apr

Tazawa Y, Wada M, Mitsukura Y, Takamiya A, Kitazawa M, Yoshimura M, Mimura M, Kishimoto T. Actigraphy for evaluation of mood disorders: A systematic review and meta-analysis. J Affect Disord. 2019 Apr 22;253:257-269. doi:10.1016/j.jad.2019.04.087. [Epub ahead of print] Review. PubMed PMID: 31060012.

​

2019 

Yoshida K, Yamaoka Y, Eguchi Y, Sato D, Iiboshi K, Kishimoto M, Mimura M, Kishimoto T†. Remote neuropsychological assessment of elderly Japanese population using the Alzheimer's Disease Assessment Scale: A validation study. J Telemed Telecare. 2020 Aug-Sep;26(7-8):482-487.

 

2019 

Kishimoto T, Hagi K, Nitta M, Kane JM, Correll CU†. Long-term effectiveness of oral second-generation antipsychotics in patients with schizophrenia and related disorders: a systematic review and meta-analysis of direct head-to-head comparisons. World Psychiatry. 2019 Jun;18(2):208-224. 

 

2019 

Moriguchi S, Takamiya A, Noda Y, Horita N, Wada M, Tsugawa S, Plitman E, Sano Y, Tarumi R, ElSalhy M, Katayama N, Ogyu K, Miyazaki T, Kishimoto T, Graff-Guerrero A, Meyer JH, Blumberger DM, Daskalakis ZJ, Mimura M, Nakajima S. Glutamatergic Neurometabolite Levels in Major Depressive Disorder: A Systematic Review and Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies. Mol Psychiatry. 2019; 24(7):952-964.

​

2019 Mar

Takamiya A, Sawada K, Hirano J, Mimura M, Kishimoto T. Prolonged Post-Electroconvulsive Therapy Delirium Controlled With Donepezil. J ECT. 2019; 35(3):e29-e30.

​

2019 Feb
Takamiya A, Hirano J, Yamagata B, Takei S, Kishimoto T, Mimura M.Electroconvulsive Therapy Modulates Resting-State EEG Oscillatory Pattern and Phase Synchronization in Nodes of the Default Mode Network in Patients With Depressive Disorder. Front Hum Neurosci. 2019 Feb 1;13:1. doi:10.3389/fnhum.2019.00001.
 

2019 Jan

Takamiya A, Sawada K, Mimura M, Kishimoto T†. Attitudes Toward Electroconvulsive Therapy Among Involuntary and Voluntary Patients. J ECT. 2019; 35(3):165-169. 

​

Kishimoto T, Takamiya A, Liang K, Funaki K, Fujita T, Kitazawa M, Yoshimura M, Tazawa Y, Horigome T, Eguchi Y, Kikuchi T, Tomita M, Bun S, Murakami J, Sumali B, Warnita T, Kishi A, Yotsui M, Toyoshiba H, Mitsukura Y, Shinoda K, Sakakibara Y, Mimura M, collaborators on behalf of the P. The Project for Objective Measures Using Computational Psychiatry Technology (PROMPT): Rationale, Design, and Methodology. medRxiv [Internet]. 2019 Jan 1;19013011. Available from: http://medrxiv.org/content/early/2019/11/29/19013011.abstract
 

2019

Sumali B, Mitsukura Y, Tazawa Y, Kishimoto T. Facial Landmark Activity Features for Depression Screening. 2019 58th Annual Conference of the Society of Instrument and Control Engineers of Japan, SICE 2019,1376-1381,2019.

​

2019 Aug

北沢桃子, 吉村道孝, 村田まゆ, 藤本友香, 一言英文, 三村　將, 坪田一男, 岸本泰士郎†. 日本の大学生におけるインターネット使用と精神症状との関連, 精神神経学雑誌, 2019.08, 121(8);  593-601

​

​

2018

​

2018 Dec

Kitazawa M,Sakamoto C, Yoshimura M, Kawashima M, Inoue S, Mimura M, Tsubota K,Negishi K, Kishimoto T. The Relationship of Dry Eye Disease with Depression and Anxiety: A Naturalistic Observational Study. Transl Vis Sci Technol. 2018 Dec 28;7(6):35. doi: 10.1167/tvst.7.6.35.

 

2018 Nov

Ayaki M, Tsubota K, Kawashima M, Kishimoto T, Mimura M, Negishi K. Sleep Disorders are a Prevalent and Serious Comorbidity in Dry Eye. Invest Ophthalmol Vis Sci. 2018; 59(14):DES143-DES150. 

​

2018 Nov
Matsumoto T, Sutoh C, Asano K, Seki Y, Urao Y, Yokoo M, Takanashi R, Yoshida T, Tanaka M, Noguchi R, Nagata S, Ohshiro K, Numata N, Hirose M, Yoshimura K, Nagai K, Nakagawa A, Sato Y, Shimizu E, Kishimoto T. Internet-based cognitive behavioral therapy with real-time therapist support via videoconference for patients with obsessive-compulsive disorder, panic disorder, and social anxietry disorder: A pilot single-arm trial. Journal of Medical Internet Research. Vol.##, pp?-?, doi:10.2196/12091.

​

2018

Kishimoto T, Horigome T, Takamiya A. Minocycline as a treatment for schizophrenia: Is the discussion truly finished? Lancet Psychiatry. 2018; 5(11):856-857. 

​

2018

Moriguchi S, Takamiya A, Noda Y, Horita N, Wada M, Tsugawa S, Plitman E, Sano Y, Tarumi R, ElSalhy M, Katayama N, Ogyu K, Miyazaki T, Kishimoto T, Graff-Guerrero A, Meyer JH, Blumberger DM, Daskalakis ZJ, Mimura M, Nakajima S. Glutamatergic Neurometabolite Levels in Major Depressive Disorder: A Systematic Review and Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies. Molecular Psychiatry. In Press

​

2018 Apr
Kurokawa S, Kishimoto T, Mizuno S, Masaoka T, Naganuma M, Liang KC, Kitazawa M, Nakashima M, Shindo C, Suda W, Hattori M, Kanai T, Mimura M. The Effect of Fecal Microbiota Transplantation on Psychiatric Symptoms among Patients with Irritable Bowel Syndrome, Functional Diarrhea and Functional Constipation: An Open-Label Observational Study. Journal of Affective Disorders 2018 Aug 1;235:506-512. doi:10.1016/j.jad.2018.04.038. Epub 2018 Apr 12. PubMed PMID: 29684865.

​

2018 Apr

Rubio J, Ahmed K, Correll C, Hagi K, Kishimoto T, Kane J. Breakthrough on antipsychotic maintenance medication: A study-level meta-analysis and meta-regression analysis. Schizophrenia bulletin, Volume 44, Issue suppl_1, S207–S208, doi.org/10.1093/schbul/sby016.510, April 2018

​

2018

Nagura M, Mitsukura Y, Kishimoto T, Mimura M. A practical BCG measuring system with bed sensors and algorithm for heartbeat detection, 2018 IEEE 15th International Workshop on Advanced Motion Control (AMC), Tokyo, 2018, pp. 317-321.doi: 10.1109/AMC.2019.8371110.

​

2018
Kitazawa M, Yoshimura M, Murata M, Sato-Fujimoto Y, Hitokoto H, Mimura M, Tsubota K, Kishimoto T. Associations between Problematic Internet Use and Psychiatric Symptoms among University Students in Japan. Psychiatry and Clinical Neurosciences. 2018 Jul;72(7):531-539. doi: 10.1111/pcn.12662. Epub 2018 May 9.

​

2018

Nagura M, Mitsukura Y, Kishimoto T, Mimura M. An estimation of heart rate variability from ballistocardiogram measured with bed leg sensors. 2018 IEEE International Conference on Industrial Technology (ICIT), 2018, 2005-2009.

​

2018

Takamiya A, Chung JK, Plitman E, Chakravarty M, Sawada K, Hirano J, Yamagata B, Graff-Guerrero A, Kishimoto T, Mimura M. T154. Electroconvulsive Therapy Induces Age-Dependent Volume Increase in the Human Dentate Gyrus. Biological Psychiatry. 2018. 83(9). S188. DOI: https://doi.org/10.1016/j.biopsych.2018.02.491.
 

​

2018
山田成志, 垂水沙梨, 吉田和生, 岸本泰士郎. 遠隔診療は対面診療に劣るか？－文献や自験例からの考察－, 精神療法, 44(4): 76-79, 2018 

2018 Oct
三澤史斉, 岸本泰士郞. 我が国におけるクロザピン使用規制の特徴：諸外国との比較, 臨床精神薬理, 21(11), 星和書店, page from-to, 2018.10

2018 Aug
山田 成志, 垂水 沙梨, 吉田 和生, 岸本泰士郎. 遠隔診療は対面診療に劣るか？―文献や自験例からの考察―, 精神療法, 44(4), 金剛出版, 76-79, 2018.8

2018 Jul
岸本泰士郎, 佐藤大介, 吉田和生, 藤田卓仙. 精神科領域における遠隔医療の展望とビッグデータ活用の可能性, 分子精神医学, 18(3), 先端医学社, 29-34, 2018.7

2018 Jun
岸本泰士郎. 情報通信技術（ICT）や人工知能（AI）を活用した精神科診療支援の試み, 東京都医師会雑誌, 71(5), 22-23, 2018.6

2018 Jun
桑原達郎, 野村総一郎, 岸本泰士郎ほか:本田明編:精神科身体合併症マニュアル第２版.医学書院, 東京, 307-313,331-334, 2018.6

​

​

2017

​

2017 Nov
Takamiya A, Chung JK, Liang KC, Graff-Guerrero A, Mimura M, Kishimoto T. Effect of electroconvulsive therapy on hippocampal and amygdala volumes: systematic review and meta-analysis. Br J Psychiatry. 2018 Jan;212(1):19-26. doi:10.1192/bjp.2017.11. PubMed PMID: 29433612.

​

2017
Kitazawa M, Yoshimura M, Kuo-Ching L, Wada S, Mimura M, Tsubota K, Kishimoto T. Utilization of Facial Image Sensing Technology for Blink Detection: A Validation Study. Eye and Contact Lenz. 2018 Jun 25. doi: 10.1097/ICL.0000000000000513.

​

2017 Jun
Mizuno S, Masaoka T, Naganuma M, Kishimoto T, Kitazawa M, Kurokawa S, Nakashima M, Takeshita K, Suda W, Mimura M, Hattori M, Kanai T. Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome. Digestion. 2017 Jun 21;96(1):29-38.

​

2017 Jul
Kishimoto T, Hagi K, Nitta M, Stefan Leucht, Mark Olfson, Kane JM, Correll CU. Effectiveness of Long-Acting Injectable vs Oral Antipsychotics in Patients with Schizophrenia: A Meta-Analysis of Prospective and Retrospective Cohort Studies. Schizophrenia Bulletin,  https://doi.org/10.1093/schbul/sbx090 , 2017 July 27.

​

2017 May
Kishimoto T, Sanghani S, Russ MJ, Marsh AN, Morris J, Basu S, Kane JM. Indications for and use of long-acting injectable antipsychotics: consideration from an inpatient setting. Int Clin Psychopharmacol. 2017 May;32(3):161-8.

​

2017 Dec
Xiang YT, Kato TA, Kishimoto T, Ungvari GS, Chiu HF, Si TM, Yang SY, Fujii S, Ng CH, Shinfuku N. Comparison of treatment patterns in schizophrenia between China and Japan (2001-2009). Asia-Pacific Psychiatry. 2017 Dec;9(4).

​

2017 Mar
Yoshimura M, Kitazawa M, Maeda Y, Mimura M, Tsubota K, Kishimoto T. Smartphone Viewing Distance and Sleep: An Experimental Study Utilizing Motion Capture Technology. Nature and Science of Sleep. 2017 Mar 8;9:59-65.

​

2017
Takamiya A, Hirano J, Ebuchi Y, Ogino S, Shimegi K, Emura H, Yonemori K, Shimazawa A, Miura G, Hyodo A, Hyodo S, Nagai T, Funaki M, Sugihara M, Kita M, Yamagata B, Mimura M, High-dose antidepressants affect near-infrared spectroscopy signals: A retrospective study. NeuroImage Clin 2017; 14: 648–655

2017    
Hirano J, Takamiya A, Yamagata B, Hotta S, Miyasaka Y, Pu S, Iwanami A, Uchida H, Mimura M. Frontal and temporal cortical functional recovery after electroconvulsive therapy for depression: A longitudinal functional near-infrared spectroscopy study    J Psychiatr Res 2017; 91: 26–35

​

2017    
Kito S, Hasegawa T, Takamiya A, Noda T, Nakagome K, Higuchi T, Koga Y, Transcranial Magnetic Stimulation Modulates Resting EEG Functional Connectivity Between the Left Dorsolateral Prefrontal Cortex and Limbic Regions in Medicated Patients With Treatment-Resistant Depression, J Neuropyschiatry Clin Neurosci 2017; 29 (2): 155–159

 

2017 
飯干紀代子,  岸本泰士郎, 江口洋子, 加藤佑佳, 松岡照之, 成本迅, 三村將. テレビ会議システムを用いた時計描画検査の信頼性, 高次脳機能研究(1348-4818). 2017.06, 37(2);220-227

​

2017 Nov
岸本泰士郎, リョウコクケイ, 工藤弘毅, 吉村道孝, 田澤雄基, 吉田和生. 情報通信技術や機械学習を活用した精神疾患重症度評価への取り組み. 情報管理. 2017,Nov:60(8); 574-582

​

2017 Dec
岸本泰士郎. 精神科の遠隔医療, 図説・日本の遠隔医療2017, 一般社団法人 日本遠隔医療学会, 44-45, 2017.12 

 

2017 Nov
岸本泰士郎. 持効性抗精神病薬の有効性証明への課題, 臨床精神薬理 20(11), 星和書店, 1233-1240, 2017.11

 

2017 Oct
髙宮彰紘, 冨尾亮介, 岸本泰士郎, 三村將. うつ病に対する脳深部刺激療法, 日本臨床 75(10), 1606-1611, 2017.10

 

2017 Sep
岸本泰士郎, 工藤弘毅, 田澤雄基. 精神疾患における臨床症状定量化－情報通信技術や機械学習を用いたアプローチ, 精神医学 59(9), 医学書院; 855-861,2017.9

​

2017 Jul

高宮彰紘，岸本泰士郎，三村將，治療抵抗性うつ病に対する脳深部刺激療法，精神科，30(6), 2017.6

​

2017 Jun
黒川駿哉, 岸本泰士郎, 三村將. 腸内細菌と精神疾患, Progress in Medicine 37, 699-703, 2017.6

 

2017 Jun
岸本泰士郎. メディカルジャーナル 人工知能が医療を変える, NHKテキスト きょうの健康 6月号, 90-93, 2017.6

 

2017 May
岸本泰士郎. 本邦における遠隔精神医療の展望, 精神科 30(5), 科学評論社;409-414,2017.5

 

2017 May
垂水沙梨, 山田成志, 岸本泰士郎. 強迫症に対する遠隔で行う曝露反応妨害法の選択的レビュー, 精神科治療学 32(4), 科学評論社; 515-518, 2017.4

​

2017 Mar
岸本泰士郎, 医療分野におけるビッグデータ並びにICT・AIの利活用の最新動向―プロジェクト「PROMPT」の概要　医療（解析センサー）機器や解析手法の特徴及び人工知能の活用の実際, 創薬資源調査報告書, 公益財団法人 ヒューマンサイエンス振興財団, 2017.3;41-47

 

2017 Mar
三村 將 編集, 岸本泰士郎 著, 「代表的な評価尺度」, 精神科レジデントマニュアル, 医学書院, 東京, 2017.3.15;314-323
 

2017 Mar

三村 將 編集, 岸本泰士郎 著, 「強迫症，ためこみ症」, 精神科レジデントマニュアル, 医学書院, 東京, 2017.3.15;183-186

 

2017 Mar

三村 將 編集, 岸本泰士郎 著, 「ひきこもり」, 精神科レジデントマニュアル, 医学書院, 東京, 2017.3.15;130-132
 

2017 Mar

三村 將 編集, 岸本泰士郎 著, 「強迫－強迫観念,強迫行為」, 精神科レジデントマニュアル, 医学書院, 東京, 2017.3.15;126-129
 

2017 Mar

三村 將 編集, 岸本泰士郎 著, 「評価尺度」, 精神科レジデントマニュアル, 医学書院, 東京, 2017.3.15;45-47
 

2017 Mar

橋本 正弘, 藤田 卓仙, 岸本泰士郎, 「人工知能・機械学習を用いた精神科診療の可能性」, 精神科 第30巻 第3号, 科学評論社, 2017,Mar:30(3);257-262

​

2016

 

2016 Oct
Ayaki M, Kawashima M, Negishi K, Kishimoto T, Mimura M, Tsubota K. Sleep and mood disorders in women with dry eye disease. Scientific Reports. 2016 Oct 12;6:35276.

​

2016 Nov
Uchida T, Kishimoto T, Koreki A, Nakao S, Owada A, Koizumi T, Saito A, Sato M,Sawada S, Matsuzaki R, Petrides G, Mimura M. Predictors of readmission after successful electroconvulsive therapy for depression: a chart review study. Int J Psychiatry Clin Pract. 2016 Nov;20(4):260-4.

​

2016 Oct
Lo Cascio N, Saba R, Hauser M, Vernal DL, Al-Jadiri A, Borenstein Y, Sheridan EM, Kishimoto T, Armando M, Vicari S, Fiori Nastro P, Girardi P, Gebhardt E, Kane JM, Auther A, Carrión RE, Cornblatt BA, Schimmelmann BG, Schultze-Lutter F, Correll CU. Attenuated psychotic and basic symptom characteristics in adolescents with ultra-high risk criteria for psychosis, other non-psychotic psychiatric disorders and early-onset psychosis. Eur Child Adolesc Psychiatry. 2016 Oct;25(10):1091-102.

 

2016 Oct
Misawa F, Hagi K, Kishimoto T, Kane JM, Correll CU. Safety and tolerability of long-acting injectable versus oral antipsychotics: a meta-analysis of randomized controlled studies comparing the same antipsychotics. Schizophrenia Research. 2016 Oct;176(2-3):220-30

​

2016
Yoshimura M, Kitazawa M, Kishimoto T, Mimura M, Tsubota K. A Survey of Japanese young adult’s postures when using smartphones before sleeping. Journal MTM. 2016, 5:2:51-53.

​

2016 Feb
Kishimoto T, Chawla JM, Hagi K, Zarate CA, Kane JM, Bauer M, Correll CU. Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories. Psychol Med. 2016 Feb 12:1-14. 

​

2016 Feb
Nielsen J, Young C, Ifteni P, Kishimoto T, Xian YT, Schukte PF, Correll CU, Taylor D. Worldwide differences in regulations of clozapine use. CNS Drugs. 2016 Feb 30(2):149-61. 

​

2016 Feb
Takaesu Y, Kishimoto T, Murakoshi A, Takahashi N, Inoue Y. Factors associated with discontinuation of aripiprazole treatment after switching from other antipsychotics in patients with chronic schizophrenia: A prospective observational study. Psychiatry Res. 2016 Feb 28;236:71-4.

​

2016 Mar
Ayaki M, Kawashima M, Negishi K, Kishimoto T, Mimura M, Tsubota K. Sleep and mood disorders in dry eye disease and allied irritating ocular diseases . Sci Rep.2016 Mar 1;6:22480.

​

2016
Kishimoto T, Correll CU, Kane JM. Comparative effectiveness of oral antipsychotics and long-acting injectable antipsychotics. Antipsychotic Long-Acting Injections 2nd. Oxford University Press. UK.2016:87-98

​

2016
Kane JM, Kishimoto T, Correll CU. Evaluation and management of treatment-resistant schizophrenia. UpToDate. http://www.uptodate.com/contents/treatment-resistant-schizophrenia?source=search_result&search=schizophrenia+treatment+refractory&selectedTitle=1~150

 

2016
岸本泰士郎, 江口洋子, 飯干紀代子, 北沢桃子, 梁國經, 船木桂, 成本迅, 三村將. 高齢者に対するビデオ会議システムを用いた改訂長谷川式簡易知能評価スケールの信頼性試験. 日本遠隔医療学会雑誌. 2016,12(2);145-148

 

2016
岸本泰士郎, 垂水沙梨, 中前貴, 三村將. 遠隔で行った強迫症に対する曝露反応妨害法：3症例のケースシリーズ. 臨床精神医学 2016,45(12);1603 -1609

​

2016

五十嵐桂, 藤井康男, 三澤史斉, 岸本泰士郎. 統合失調症患者における死亡率と突然死についての検討. 臨床精神薬理 2016,19(7);1003-1014

​

2016 Mar
垂水沙梨, 岸本泰士郎. 強迫性障害に対する遠隔医療：レビューと取り組みの紹介. 精神科治療学 2016,Mar:31(3);407-410

​

2016
岸本 泰士郎. 臨床研究デザインの限界に注目しながら持効性注射剤（LAI）の効果について検証する―LAI賛成の立場から―, 精神神経学雑誌, 2016,118(8);607-614

2016 Oct
岸本 泰士郎, 三村 將 共著. 不安症・強迫症の疾患概念, 今日の精神疾患治療指針 第2版, 医学書院, 東京, 2016.10.15;160-165

​

2016 Oct
岸本 泰士郎, 内田 裕之, 鈴木 健文, 三村 將 共訳. 「抗精神病薬の予防的投与」, 「抗精神病薬の併用療法」, 「陰性症状」, 「モニタリング」, 「有害事象の相対的評価概覧」, 「統合失調症の治療アルゴリズム」, 「第一世代抗精神病薬－治療における位置づけ」, 「統合失調症とオメガ３脂肪酸（魚油）」, 「統合失調症の新しい薬剤, 開発中の薬剤」, 「統合失調症治療のNICEガイドライン」, モーズレイ処方ガイドライン 第12版 上巻, ワイリー・パブリッシング・ジャパン株式会社, 東京, 2016.10.1;29-56

​

2016 Oct
岸本 泰士郎, 疾患ステージから見た統合失調症薬物療法：試験デザインの限界に関する考察を含めて, 臨床精神薬理, 2016,Oct:19(10);1411-1417

​

2016 Sep
岸本 泰士郎, カルバマゼピン：気分安定薬としての開発経緯と今日の役割, 精神科, 2016,Sept:29(3);207-212

 

2016 Aug
岸本 泰士郎, 統合失調症の再発をより確実に予防するために－メタ解析に基づく検討－, 東京こころのクリニック, Aug. 2016,16;142-151

​

2016
工藤弘毅, 岸本泰士郎. 双極性障害における閾値下症状の考え方と早期介入, 精神医学 58(7) ：581-589，2016

 

2016 Jul
岸本 泰士郎, 統合失調症のリカバリーを見据えた薬物療法, 精神科臨床 Legato, 2016,July: 2(3);24-28

 

2016

伊藤侯輝, 金沢徹文, 岸本泰士郎, 竹内啓善, 菱本明豊. 維持期治療. 統合失調症薬物治療ガイドライン（日本神経精神薬理学会 編）医学書院（東京）, 2016：40-61

 

2016

Kishimoto T, Ito K, Takamiya A, Yoshinaga S. Japanese PDAS, The Psychotic Depression Assessment Scale (PDAS). 2016, http://psychoticdepressionassessmentscale.com/japanese-pdas/

​

2016 Mar
岸本泰士郎, 統合失調症のリカバリー達成に向けて薬物療法にできること,臨床精神薬理. 2016,Mar:19(3):259-265

 

2016
伊藤侯輝, 金沢徹文, 岸本泰士郎, 竹内啓善, 菱本明豊. 統合失調症薬物治療ガイドライン 維持期. 日本神経精神薬理学会編. http://www.asas.or.jp/jsnp/img/csrinfo/togoshiccho_03.pdf

​

2016       

鬼頭伸輔，長谷川崇，高宮彰紘，うつ病のTMS療法，金原出版

​

​

2015

​

2015
Correll CU; Kishimoto T; John M. Kane. Do Long-Acting Injectable Antipsychotics Improve Adherence and Related Outcomes?, www.cmeinstitute.com/pages/lets-talk.aspx?bid=118, 2015

​

2015
Haddad PM, Kishimoto T, Correll CU, Kane JM. Ambiguous findings concerning potential advantages of depot antipsychotics: in search of clinical relevance. Curr Opin Psychiatry 28(3):216-21, 2015

​

2015
Gerstenberg M, Hauser M, Al-Jadiri A, Sheridan EM, Kishimoto T, Borenstein Y, Vernal DL, David L, Saito E, Landers SE, Carella M, Singh S, Carbon M, Jiménez-Fernández S, Birnbaum ML, Auther A, Carrión RE, Cornblatt BA, Kane JM, Walitza S, Correll CU. Frequency and correlates of DSM-5 attenuated psychosis syndrome in a sample of adolescent inpatients with nonpsychotic psychiatric disorders. J Clin Psychiatry 76(11):e1449-58, 2015

​

2015 Nov-Dec
Takamiya A, Kishimoto T, Watanabe K, Mimura M, Kito S. Transcranial Magnetic Stimulation for Bipolar Disorder with Catatonic Stupor: A Case Report. Brain Stimul. 2015 Nov-Dec;8(6):1236-7.

​

2015

Iiboshi K, Kohriyama K, Kato Y, Matsuoka T, Narumoto J, Eguchi Y, Kishimoto T, Mimura M, Awazu K, Iwamaru H. Capacity test in financial activities of elderly: Preliminary study, INTERNATIONAL PSYCHOGERIATRICS, Volume 27, S141-S142, 2015

​

2015
岸本泰士郎. 統合失調症（維持期）精神科治療における処方ガイドブック. 精神科治療学 30(増刊号):36-39, 2015
 
2015 Oct
堀込俊郎, 岸本泰士郎.【免疫と精神神経疾患】躁うつ病, 精神科, 2015,Oct,27(4):241-245

 

2015 Jul
岸本泰士郎. 経口薬と比較した抗精神病薬持効性注射剤(LAI)の再発予防効果,精神科治療学,2015,Jul:30(7);931-937

 

2015 Jul
岸本泰士郎. 【抗精神病薬特効性注射剤(LAI)を投与する際に知っておくべき点】LAIの効果, 精神科, 2015,Jul:27(1):22-27

​

2015 Jun
岸本泰士郎. 持効性注射剤(LAI)の経口抗精神病薬に比した効果と副作用についてのエビデンス：メタ解析に基づく検討,臨床精神薬理,2015,Jun:18(6):695-730

​

2015 Jun
岸本泰士郎. 持効性注射薬剤のベネフィットとリスク, 臨床精神薬理, 2015.Jun:18(6):695-703

​

2015       

髙宮彰紘, 鬼頭伸輔，精神医学の基盤 [2]うつ病に対するneuromodulation，学樹書院

 

2015       

髙宮彰紘, 鬼頭伸輔，精神疾患に対する脳深部刺激療法，脳21 vol. 18 No.1 20-25, 2015

 

2015       

髙宮彰紘, 三村將 Neuromodulation 精神科治療学 vol.30 No.5, 2015

​

​

2014

​

2014 Jan
Kishimoto T, Robenzadeh A, Leucht C, Leucht S, Watanabe K, Mimura M, Borenstein M, Kane JM, Correll CU. Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trials. Schizophr Bull. 2014 Jan;40(1):192-213. 

​

2014 Aug
Correll CU, Olvet DM, Auther AM, Hauser M, Kishimoto T, Carrión RE, Snyder S, Cornblatt BA. The Bipolar Prodrome Symptom Interview and Scale-Prospective (BPSS-P): description and validation in a psychiatric sample and healthy controls. Bipolar Disord. 2014 Aug;16(5):505-22.

​

2014

Correll C, Kishimoto T, Loewy R, Kane JM. New developments in the early recognition of individuals at risk for or with emerging schizophrenia and bipolar spectrum disorders. Early Intervention in Psychiatry, 8:29-29, 2014

​

2014
岸本泰士郎. 特効性抗精神病薬注射剤(LAI)と経口抗精神病薬の再発予防効果を比較したメタ解析. 臨床精神薬理 2014,17(3):337-343.

​

2014
岸本泰士郎. 身体合併症と精神科薬物療法:抗精神病薬を中心とした選択的レビュー,臨床精神医学, 2014,43(3):349-355.

​

2014
岸本泰士郎. 【統合失調症と身体の健康】骨粗鬆症・骨折, 統合失調症　第7巻 2014, 85-90, 医薬ジャーナル社, 大阪市.

 

2014       

髙宮彰紘, 三村將 新しいうつ病治療 - 脳深部刺激(DBS) -, 最新医学, 69(o.9)1872-1876, 2014.

 

2014       

髙宮彰紘, 田中謙二, 時流解説 うつ病治療におけるDBSについて,  DEPRESSION JOURNAL, 2(2), 26-27, 2014

​

​

2013

​

2013 Dec
Stentebjerg-Olesen M, Jeppesen P, Pagsberg AK, Fink-Jensen A, Kapoor S, Chekuri R, Carbon M, Al-Jadiri A, Kishimoto T, Kane JM, Correll CU. Early nonresponse determined by the clinical global impressions scale predicts poorer outcomes in youth with schizophrenia spectrum disorders naturalistically treated with second-generation antipsychotics. J Child Adolesc Psychopharmacol. 2013 Dec;23(10):665-75.

​

2013 Oct
Kishimoto T, Nitta M, Borenstein M, Kane JM, Correll CU. Long Acting Injectable vs. Oral Antipsychotics in Schizophrenia: A Systematic Review and Meta-Analysis of Mirror-Image Studies. J Clin Psychiatry. 2013 Oct;74(10):957-65.

​

2013
Hirano J, Watanabe K, Suzuki T, Uchida H, Den R, Kishimoto T, Nagasawa T, Tomita Y, Hara K, Ochi H, Kobayashi Y, Ishii M, Fujita A, Kanai Y, Goto M, Hayashi H, Inamura K, Ooshima F, Sumida M, Ozawa T, Sekigawa K, Nagaoka M, Yoshimura K, Konishi M, Inagaki A, Saito T, Motohashi N, Mimura M, Okubo Y, Kato M. An open-label study of algorithm-based treatment versus treatment-as-usual for patients with schizophrenia. Neuropsychiatr Dis Treat. 2013;9:1553-64. 

 

2013 Jul
Takahashi T, Uchida H, John M, Hirano J, Watanabe K, Mimura M, Correll CU, Kishimoto T. The impact of prolactin-raising antipsychotics on bone mineral density in patients with schizophrenia: findings from a longitudinal observational cohort. Schizophr Res. 2013 Jul;147(2-3):383-6. 

​

2013 Oct
Kane JM, Kishimoto T, Correll CU. Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies. World Psychiatry. 2013 Oct;12(3):216-26. 

​

2013 Aug
Kane JM, Kishimoto T, Correll CU. Assessing the comparative effectiveness of long-acting injectable vs. oral antipsychotic medications in the prevention of relapse provides a case study in comparative effectiveness research in psychiatry. J Clin Epidemiol. 2013 Aug;66(8 Suppl):S37-41. 

​

2013 Nov
Nitta M, Kishimoto T, Müller N, Weiser M, Davidson M, Kane JM, Correll CU. Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials. Schizophr Bull. 2013 Nov;39(6):1230-41.

​

2013 Oct
Kishimoto T, Watanabe K, Uchida H, Mimura M, Kane JM, Correll CU. Antipsychotic polypharmacy: a Japanese survey of prescribers' attitudes and rationales. Psychiatry Res. 2013 Oct 30;209(3):406-11.

2013 Jan
Kishimoto T, Agarwal V, Kishi T, Leucht S, Kane JM, Correll CU. Relapse prevention in schizophrenia: a systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsychotics. Mol Psychiatry. 2013 Jan;18(1):53-66.

​

​

​

2013
岸本泰士郎. 向精神薬の併用療法：海外における実態や予測因子に関する選択的レビュー. 臨床精神医学. 2013; 42(2), 159-167

​

​

2012

 

2012 Sep
Kishimoto T, De Hert M, Carlson HE, Manu P, Correll CU. Osteoporosis and fracture risk in people with schizophrenia. Curr Opin Psychiatry. 2012 Sep;25(5):415-429.

​

​2012

Abbs B, Achalia RM, Adelufosi AO, Aktener AY, Beveridge NJ, Bhakta SG, Blackman RK, Bora E, Byun MS, Cabanis M, Carrion R, Castellani CA, Chow TJ, Dmitrzak-Weglarz M, Gayer-Anderson C, Gomes FV, Haut K, Hori H, Kantrowitz JT, Kishimoto T, Lee FH, Lin A, Palaniyappan L, Quan M, Rubio MD, Ruiz de Azúa S, Sahoo S, Strauss GP, Szczepankiewicz A, Thompson AD, Trotta A, Tully LM, Uchida H, Velthorst E, Young JW, O'Shea A, Delisi LE. The 3rd Schizophrenia International Research Society Conference, 14-18 April 2012, Florence, Italy: summaries of oral sessions. Schizophr Res. 2012 Oct;141(1):e1-e24.

 

​

2011

 

2011

Correll CU, Kishimoto T, Kane JM. Randomized controlled trials in schizophrenia: opportunities, limitations, and trial design alternatives. Dialogues Clin Neurosci. 2011;13(2):155-72.

​